{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:54:05Z","timestamp":1785196445820,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm Regener"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Idiopathic inflammatory myopathies (IIMs) are a group of autoimmune disorders characterized by immune cell infiltration of muscle tissue accompanied by inflammation. Treatment of IIMs is challenging, with few effective therapeutic options due to the lack of appropriate models that successfully recapitulate the features of IIMs observed in humans. In the present study, we demonstrate that immunodeficient mice transplanted with human peripheral blood mononuclear cells (hPBMCs) exhibit the key pathologic features of myositis observed in humans and develop graft-versus-host disease. The hPBMC mice exhibit elevated serum levels of creatine kinase and aspartate transaminase, markers of myositis, and increased expression levels of myositis-related genes, such as vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and serum amyloid A1, in muscle tissues. Histopathologic and flow cytometric analyses reveal the infiltration of CD8<jats:sup>+<\/jats:sup> T cells in the muscle tissue of hPBMC mice, similar to that observed in patients with myositis, particularly in those with polymyositis. Transplantation of CD8<jats:sup>+<\/jats:sup> T cell-depleted hPBMC leads to a significant reduction in polymyositis-like symptoms, in agreement with previous studies demonstrating CD8<jats:sup>+<\/jats:sup> T cells as the main pathologic drivers of polymyositis. Furthermore, the transcriptome analysis of muscle tissue from hPBMC mice reveal extensive upregulation of characteristic genes of polymyositis, providing further support that hPBMC mice accurately reflect the pathophysiology of myositis in humans. Finally, administration of prednisolone or tacrolimus, which are commonly used for IIM treatment, leads to significant alleviation of myositis findings. Therefore, we propose that hPBMC mice should be considered as a model that accurately reflects the pathophysiology of myositis in human patients.<\/jats:p>","DOI":"10.1186\/s41232-025-00365-6","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T02:15:09Z","timestamp":1736907309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Human PBMC-based humanized mice exhibit myositis features and serve as a drug evaluation model"],"prefix":"10.1186","volume":"45","author":[{"given":"Akiko","family":"Nishidate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Imura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"Murase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Anan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuka","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Airi","family":"Akatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Koda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"issue":"1","key":"365_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, et al. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021;7(1):86.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"365_CR2","first-page":"456","volume":"140","author":"M Gayraud","year":"1989","unstructured":"Gayraud M, Guillevin L. Classification of myositis. Ann Med Interne (Paris). 1989;140(6):456\u20138.","journal-title":"Ann Med Interne (Paris)"},{"issue":"5","key":"365_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/mus.23302","volume":"45","author":"DE Furst","year":"2012","unstructured":"Furst DE, Amato AA, Iorga SR, Gajria K, Fernandes AW. Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve. 2012;45(5):676\u2013835.","journal-title":"Muscle Nerve."},{"issue":"2","key":"365_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.33403","volume":"64","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, Kodera M, et al. Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum. 2012;64(2):513\u201322.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"365_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/rheumatology\/kex413","volume":"57","author":"I Pinal-Fernandez","year":"2018","unstructured":"Pinal-Fernandez I, Ferrer-Fabregas B, Trallero-Araguas E, Balada E, Martinez MA, Milisenda JC, et al. Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis. Rheumatology (Oxford). 2018;57(2):388\u201396.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"365_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ana.410190203","volume":"19","author":"K Arahata","year":"1986","unstructured":"Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. III: immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann Neurol. 1986;19(2):112\u201325.","journal-title":"Ann Neurol."},{"issue":"2","key":"365_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.410230210","volume":"23","author":"K Arahata","year":"1988","unstructured":"Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. IV: cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol. 1988;23(2):168\u201373.","journal-title":"Ann Neurol."},{"issue":"2","key":"365_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.410160206","volume":"16","author":"K Arahata","year":"1984","unstructured":"Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol. 1984;16(2):193\u2013208.","journal-title":"Ann Neurol."},{"issue":"2","key":"365_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ana.410160207","volume":"16","author":"AG Engel","year":"1984","unstructured":"Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol. 1984;16(2):209\u201315.","journal-title":"Ann Neurol."},{"issue":"9388","key":"365_CR10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362(9388):971\u201382.","journal-title":"Lancet"},{"issue":"3","key":"365_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.berh.2004.03.003","volume":"18","author":"RD Sontheimer","year":"2004","unstructured":"Sontheimer RD. Skin manifestations of systemic autoimmune connective tissue disease: diagnostics and therapeutics. Best Pract Res Clin Rheumatol. 2004;18(3):429\u201362.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"365_CR12","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/S2665-9913(23)00322-3","volume":"6","author":"CM Connolly","year":"2024","unstructured":"Connolly CM, Gupta L, Fujimoto M, Machado PM, Paik JJ. Idiopathic inflammatory myopathies: current insights and future frontiers. Lancet Rheumatol. 2024;6(2):e115\u201327.","journal-title":"Lancet Rheumatol"},{"key":"365_CR13","unstructured":"Yasir M, Goyal A, Sonthalia S. Corticosteroid adverse effects. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Amandeep Goyal declares no relevant financial relationships with ineligible companies. Disclosure: Sidharth Sonthalia declares no relevant financial relationships with ineligible companies.2024."},{"issue":"5","key":"365_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrrheum.2018.42","volume":"14","author":"CV Oddis","year":"2018","unstructured":"Oddis CV, Aggarwal R. Treatment in myositis. Nat Rev Rheumatol. 2018;14(5):279\u201389.","journal-title":"Nat Rev Rheumatol"},{"key":"365_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejim.2023.01.018","volume":"110","author":"J Liao","year":"2023","unstructured":"Liao J, Peng X, Liu J, Xie X, Wang J. The efficacy and safety of tacrolimus in patients with dermatomyositis\/polymyositis: a meta-analysis and systematic review. Eur J Intern Med. 2023;110:35\u201340.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"365_CR16","first-page":"117","volume":"68","author":"NL Rosenberg","year":"1987","unstructured":"Rosenberg NL, Ringel SP, Kotzin BL. Experimental autoimmune myositis in SJL\/J mice. Clin Exp Immunol. 1987;68(1):117\u201329.","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"365_CR17","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.4049\/jimmunol.142.12.4289","volume":"142","author":"NL Rosenberg","year":"1989","unstructured":"Rosenberg NL, Kotzin BL. Aberrant expression of class II MHC antigens by skeletal muscle endothelial cells in experimental autoimmune myositis. J Immunol. 1989;142(12):4289\u201394.","journal-title":"J Immunol"},{"issue":"1\u20132","key":"365_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0022-510X(96)00223-7","volume":"144","author":"S Matsubara","year":"1996","unstructured":"Matsubara S, Okumura S. Experimental autoimmune myositis in SJL\/J mice produced by immunization with syngeneic myosin B fraction. Transfer by both immunoglobulin G and T cells. J Neurol Sci. 1996;144(1\u20132):171\u20135.","journal-title":"J Neurol Sci."},{"issue":"4","key":"365_CR19","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/art.22521","volume":"56","author":"T Sugihara","year":"2007","unstructured":"Sugihara T, Sekine C, Nakae T, Kohyama K, Harigai M, Iwakura Y, et al. A new murine model to define the critical pathologic and therapeutic mediators of polymyositis. Arthritis Rheum. 2007;56(4):1304\u201314.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"365_CR20","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/art.24689","volume":"60","author":"N Okiyama","year":"2009","unstructured":"Okiyama N, Sugihara T, Iwakura Y, Yokozeki H, Miyasaka N, Kohsaka H. Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A. Arthritis Rheum. 2009;60(8):2505\u201312.","journal-title":"Arthritis Rheum"},{"issue":"2\u20133","key":"365_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jaut.2007.07.005","volume":"29","author":"Y Katsumata","year":"2007","unstructured":"Katsumata Y, Ridgway WM, Oriss T, Gu X, Chin D, Wu Y, et al. Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation. J Autoimmun. 2007;29(2\u20133):174\u201386.","journal-title":"J Autoimmun"},{"issue":"9","key":"365_CR22","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1136\/annrheumdis-2020-218661","volume":"80","author":"N Okiyama","year":"2021","unstructured":"Okiyama N, Ichimura Y, Shobo M, Tanaka R, Kubota N, Saito A, et al. Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1gamma can result in experimental myositis. Ann Rheum Dis. 2021;80(9):1201\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"16","key":"365_CR23","doi-asserted-by":"publisher","first-page":"e2313070121","DOI":"10.1073\/pnas.2313070121","volume":"121","author":"Y Ichimura","year":"2024","unstructured":"Ichimura Y, Konishi R, Shobo M, Tanaka R, Kubota N, Kayama H, et al. Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice. Proc Natl Acad Sci U S A. 2024;121(16):e2313070121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"365_CR24","doi-asserted-by":"publisher","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","volume":"97","author":"K Nagaraju","year":"2000","unstructured":"Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, Lee E, et al. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A. 2000;97(16):9209\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"365_CR25","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100(9):3175\u201382.","journal-title":"Blood"},{"issue":"3","key":"365_CR26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1182\/blood-2002-09-2755","volume":"102","author":"H Hiramatsu","year":"2003","unstructured":"Hiramatsu H, Nishikomori R, Heike T, Ito M, Kobayashi K, Katamura K, et al. Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD\/SCID\/gammacnull mice model. Blood. 2003;102(3):873\u201380.","journal-title":"Blood"},{"issue":"5","key":"365_CR27","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1182\/blood-2005-02-0516","volume":"106","author":"F Ishikawa","year":"2005","unstructured":"Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, et al. Development of functional human blood and immune systems in NOD\/SCID\/IL2 receptor gamma chain(null) mice. Blood. 2005;106(5):1565\u201373.","journal-title":"Blood"},{"issue":"2","key":"365_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri2017","volume":"7","author":"LD Shultz","year":"2007","unstructured":"Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol. 2007;7(2):118\u201330.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"365_CR29","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","volume":"88","author":"KR Cooke","year":"1996","unstructured":"Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J Jr, Crawford JM, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood. 1996;88(8):3230\u20139.","journal-title":"Blood."},{"issue":"15","key":"365_CR30","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320.","journal-title":"Bioinformatics"},{"issue":"1","key":"365_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"key":"365_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"365_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12064-012-0162-3","volume":"131","author":"GP Wagner","year":"2012","unstructured":"Wagner GP, Kin K, Lynch VJ. Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples. Theory Biosci. 2012;131(4):281\u20135.","journal-title":"Theory Biosci"},{"issue":"2","key":"365_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/cei.12051","volume":"172","author":"H Sondergaard","year":"2013","unstructured":"Sondergaard H, Kvist PH, Haase C. Human T cells depend on functional calcineurin, tumour necrosis factor-alpha and CD80\/CD86 for expansion and activation in mice. Clin Exp Immunol. 2013;172(2):300\u201310.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"365_CR35","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s10067-021-06035-5","volume":"41","author":"K Wang","year":"2022","unstructured":"Wang K, Zhu R, Li J, Zhang Z, Wen X, Chen H, et al. Coexpression network analysis coupled with connectivity map database mining reveals novel genetic biomarkers and potential therapeutic drugs for polymyositis. Clin Rheumatol. 2022;41(6):1719\u201330.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"365_CR36","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1136\/annrheumdis-2019-216599","volume":"79","author":"I Pinal-Fernandez","year":"2020","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Derfoul A, Pak K, Miller FW, Milisenda JC, et al. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis. Ann Rheum Dis. 2020;79(9):1234\u201342.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"365_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-023-02669-8","volume":"147","author":"C Nelke","year":"2024","unstructured":"Nelke C, Schmid S, Kleefeld F, Schroeter CB, Goebel HH, Hoffmann S, et al. Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases. Acta Neuropathol. 2024;147(1):15.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"365_CR38","first-page":"593","volume":"35","author":"H Hasegawa","year":"2017","unstructured":"Hasegawa H, Kawahata K, Mizoguchi F, Okiyama N, Miyasaka N, Kohsaka H. Direct suppression of autoaggressive CD8+ T cells with CD80\/86 blockade in CD8+ T cell-mediated polymyositis models of mice. Clin Exp Rheumatol. 2017;35(4):593\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"365_CR39","doi-asserted-by":"publisher","first-page":"103131","DOI":"10.1016\/j.jaut.2023.103131","volume":"142","author":"H Sasaki","year":"2024","unstructured":"Sasaki H, Umezawa N, Itakura T, Iwai H, Yasuda S. Pathogenicity of functionally activated PD-1(+)CD8(+) cells and counterattacks by muscular PD-L1 through IFNgamma in myositis. J Autoimmun. 2024;142:103131.","journal-title":"J Autoimmun"},{"issue":"7","key":"365_CR40","first-page":"1135","volume":"23","author":"P Cherin","year":"1996","unstructured":"Cherin P, Herson S, Crevon MC, Hauw JJ, Cervera P, Galanaud P, et al. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis. J Rheumatol. 1996;23(7):1135\u201342.","journal-title":"J Rheumatol"},{"issue":"11","key":"365_CR41","doi-asserted-by":"publisher","first-page":"8415","DOI":"10.3390\/curroncol29110663","volume":"29","author":"AD Kvinge","year":"2022","unstructured":"Kvinge AD, Kvammen T, Miletic H, Bindoff LA, Reikvam H. Musculoskeletal chronic graft versus host disease-a rare complication to allogeneic hematopoietic stem cell transplant: a case-based report and review of the literature. Curr Oncol. 2022;29(11):8415\u201330.","journal-title":"Curr Oncol"},{"issue":"1","key":"365_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/bloodadvances.2019000918","volume":"4","author":"Y Inamoto","year":"2020","unstructured":"Inamoto Y, Lee SJ, Onstad LE, Flowers MED, Hamilton BK, Jagasia MH, et al. Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia. Blood Adv. 2020;4(1):40\u20136.","journal-title":"Blood Adv"},{"issue":"6","key":"365_CR43","doi-asserted-by":"publisher","first-page":"103334","DOI":"10.1016\/j.autrev.2023.103334","volume":"22","author":"M Gasparotto","year":"2023","unstructured":"Gasparotto M, Franco C, Zanatta E, Ghirardello A, Zen M, Iaccarino L, et al. The interferon in idiopathic inflammatory myopathies: different signatures and new therapeutic perspectives. A literature review. Autoimmun Rev. 2023;22(6):103334.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"365_CR44","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1073\/pnas.0914902107","volume":"107","author":"A Triantafyllopoulou","year":"2010","unstructured":"Triantafyllopoulou A, Franzke CW, Seshan SV, Perino G, Kalliolias GD, Ramanujam M, et al. Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc Natl Acad Sci U S A. 2010;107(7):3012\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"365_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/art.38907","volume":"67","author":"W Lin","year":"2015","unstructured":"Lin W, Seshasayee D, Lee WP, Caplazi P, McVay S, Suto E, et al. Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus. Arthritis Rheumatol. 2015;67(1):215\u201324.","journal-title":"Arthritis Rheumatol"},{"key":"365_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175440","volume":"938","author":"Y Kawato","year":"2023","unstructured":"Kawato Y, Fukahori H, Nakamura K, Kubo K, Hiramitsu M, Kinugasa F, et al. Development of a novel Poly (I:C)-induced murine model with accelerated lupus nephritis and examination of the therapeutic effects of mycophenolate mofetil and a cathepsin S inhibitor. Eur J Pharmacol. 2023;938: 175440.","journal-title":"Eur J Pharmacol"}],"container-title":["Inflammation and Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-025-00365-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41232-025-00365-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-025-00365-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T03:02:16Z","timestamp":1736910136000},"score":1,"resource":{"primary":{"URL":"https:\/\/inflammregen.biomedcentral.com\/articles\/10.1186\/s41232-025-00365-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["365"],"URL":"https:\/\/doi.org\/10.1186\/s41232-025-00365-6","relation":{},"ISSN":["1880-8190"],"issn-type":[{"value":"1880-8190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments involving animals were approved by the animal study committees of Mitsubishi Tanabe Pharma Corporation (Mitsubishi Tanabe Pharma Corporation, Kanagawa, Japan) and performed according to institutional guidelines and Home Office regulations. The Institutional Review Board of Mitsubishi Tanabe Pharma Corporation approved all human studies according to the Declaration of Helsinki guidelines revised in 2008.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are employees of Mitsubishi Tanabe Pharma Corporation. The authors have declared that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}